ARCHIVES

ODAC Recommends Femara Campath For FDA Approval.

This article is from The Cancer Letter archive.

Vol. 27 No. 01 | January 5, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells.

November 23, 2007

Medicare Covers All PET Scans For Cancer In New Program

May 26, 2006

ONS Again Offers Nursing Certification Exam In May, Sept

January 11, 1991

Smoking Cessation Training Follows Doctors Into Practice

October 29, 2004

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011